Projects per year
Personal profile
Education
- 1999 PhD, National Defense Medical Center, Institute of Life Sciences
Research Interests
- gene transcription
- Molecular cancer
- Molecular inflammation
- signal transduction
Experience
- 2017.08~now Professor, Department of Biotechnology and Bioindustry Sciences, NCKU, TW
- 2016.08~now Distinguished Professor, NCKU, TW
- 2015.02~now Associate Vice President of Academic Affairs, NCKU, TW
- 2015.02~now Director of Center for Faculty Development, NCKU, TW
- 2013.01~now Adjunct Professor, Graduate Institute of Medical Sciences, TMU, TW
- 2012.09~now Adjunct Professor, Institute of Pharmacology, NCKU, TW
- 2012.09~now Adjunct Professor, Institute of Basic Medical Sciences, NCKU, TW
- 2018.06-2018.08 Visiting Research Scholar, Ins. of Molecular and Cellular Oncology, MD Anderson, USA
- 2015.02~2017.12 Director of Yunlin Chiayi and Tainan Regional Teaching Resource Center, NCKU, TW
- 2013.08~2016.07 Director of Institute of Bioinformatics and Biosignal Transduction, NCKU, TW
- 2013.07~2013.09 Visiting Research Scholar, Department of Pharmacology, Kyoto University, JP
- 2012.09~2017.07 Professor, Institute of Bioinformatics and Biosignal Transduction, NCKU, TW
- 2012.07~2012.09 Visiting Research Scholar, Department of Pharmacology, Kyoto University, JP
- 2011.07~2011.09 Visiting Research Scholar, Department of Biological Chemistry, UC Irvine, USA
- 2009.09~2012.08 Associate Professor, Institute of Bioinformatics and Biosignal Transduction, NCKU, TW
- 2009.09~2012.08 Adjunct Associate Professor, Institute of Basic Medical Sciences, NCKU, TW
- 2009.09~2012.08 Adjunct Associate Professor, Institute of Pharmacology, NCKU, TW
- 2008.03~2009.08 Adjunct Assistant Professor, Institute of Basic Medical Sciences, NCKU, TW
- 2007.09~2010.08 Adjunct Assistant Professor, Institute of Bioinformatics, NCKU, TW
- 2006.09~2009.08 Assistant Professor, Institute of Biosignal Transduction, NCKU, TW
- 2006.09~2009.08 Adjunct Assistant Professor, Institute of Pharmacology, NCKU, TW
- 2005.03~2006.08 Postdoctoral, Institute of Biological Chemistry, UC Irvine, USA
- 2004.11~2005.02 Research Assistant Professor, Institute of Pharmacology, NCKU, TW
- 2003.02~2004.10 Postdoctoral, Institute of Pharmacology, NCKU, TW
- 2000.01~2003.01 Postdoctoral, Institute of Molecular Biology, Academia Sinica, TW
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 23 Finished
-
探討基質細胞中CEBPD調控PTX3基因及其於大腸直腸癌周邊微環境中的角色扮演與抑制確效
Wang, J.-M. (PI)
21-08-01 → 22-07-31
Project: Research project
-
分析及評估新穎發炎標的蛋白在晚期與抗藥性肝癌的癌化過程及治療應用之研究-探討CEBPD/PTX3 路徑角色及開發PTX3標靶應用於抗藥性肝癌的治療( III )
Wang, J.-M. (PI)
21-08-01 → 22-07-31
Project: Research project
-
探討基質細胞中CEBPD調控PTX3基因及其於大腸直腸癌周邊微環境中的角色扮演與抑制確效
Wang, J.-M. (PI)
20-08-01 → 21-07-31
Project: Research project
-
分析及評估新穎發炎標的蛋白在晚期與抗藥性肝癌的癌化過程及治療應用之研究-探討CEBPD/PTX3 路徑角色及開發PTX3標靶應用於抗藥性肝癌的治療( II )
Wang, J.-M. (PI)
20-08-01 → 21-07-31
Project: Research project
-
分析及評估新穎發炎標的蛋白在晚期與抗藥性肝癌的癌化過程及治療應用之研究-探討CEBPD/PTX3 路徑角色及開發PTX3標靶應用於抗藥性肝癌的治療(1/3)
Wang, J.-M. (PI)
19-08-01 → 20-07-31
Project: Research project
-
A novel, non-spirometric “BMP index” for predicting severe adverse outcomes in fibrosing interstitial lung diseases
Huang, T. H., Hou, H. Y., Chang, H. Y., Hu, C. H., Kuo, H. I., Er, H. P., Wu, Y. W., Lin, C. Y., Tseng, Y. L., Wang, J. M., Huang, L. T., Weng, C. T., Lin, S. H., Shieh, C. C. & Wu, C. L., 2026 Dec, In: Scientific reports. 16, 1, 2805.Research output: Contribution to journal › Article › peer-review
Open Access -
CCAAT/enhancer-binding protein delta regulates miRs-4257 and 3156 to attenuate the interleukin 12 through small extracellular vesicle transmission in glioblastoma
Chu, Y. Y., Ko, C. Y., Wang, S. M., Wang, W. J., Wang, C.-Y., Chen, F. W., Liang, H. Y. & Wang, J. M., 2026 Dec, In: Cancer Cell International. 26, 1, 149.Research output: Contribution to journal › Article › peer-review
Open Access -
HDAC4 overexpression predicts aggressive phenotypes and poor outcomes in urothelial carcinoma
Jan, H. C., Su, Y. C., Huang, S. K. H., Wang, C. A., Wang, J. M. & Li, C. F., 2026, In: Cancer Treatment and Research Communications. 47, 101148.Research output: Contribution to journal › Article › peer-review
Open Access -
DSG2 attenuates gemcitabine efficacy through PTX3 in lung adenocarcinoma
Wang, C. C., Lin, J. Y., Wang, C.-Y., Shen, W. J., Liao, P. C., Ho, Y. F., Lin, C. W., Wang, S.-A., Ko, C. C., Dey, S., Ta, H. D. K., Xuan, D. T. M., Kumar, S., William, B. T., Wang, J. M. & Wang, W. J., 2025 Aug, In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1871, 6, 167881.Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Citations (Scopus) -
Epithelial CEBPD activates fibronectin and enhances macrophage adhesion in renal ischemia-reperfusion injury
Chang, S. S., Cheng, C. C., Chen, Y. R., Chen, F. W., Cheng, Y. M. & Wang, J. M., 2024 Dec, In: Cell Death Discovery. 10, 1, 328.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Citations (Scopus)